Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

164

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-26

HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days ago

HgCapital Trust4 days ago

New Director · Appointment of ALI, Moynul as director · New director appointed · board evolution

admin

Treble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days ago

Treble Peak5 days ago

Share Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Compagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks ago

Compagnie Financière et de Participations Roullier2 weeks ago

Board change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin

Biotech United States

203 companies matching · Page 1 of 5

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Navan3 periods HTGF III	Biotech	United States	High-Tech Gruenderfonds (HTGF)	2019	7yr	Active	–	–
Evergreen Theragnostics LIFTT	Biotech	United States	LIFTT	2024	1yr	Exited 2025	Lantheus Holdings	2.1x
Kojin Therapeutics2 periods Cathay Health	Biotech	United States	Cathay Capital	2021	4yr	Exited 2025	–	–
CARGO Therapeutics Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2024	1yr	Exited 2025	Concentra Biosciences	–
Dorian Therapeutics Vento Fund I	Biotech	United States	Vento	2023	2yr	Exited 2025	Altos Labs	–
Inozyme Pharma Novo Holdings Principal Investments	Biotech	United States	Novo Holdings	2023	2yr	Exited 2025	BioMarin Pharmaceutical	–
Boundless Bio Leaps by Bayer	Biotech	United States	Leaps by Bayer	2023	1yr	Exited 2024	–	–
Metagenomi Leaps by Bayer	Biotech	United States	Leaps by Bayer	2020	4yr	Exited 2024	–	–
Morphic Therapeutic Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2023	1yr	Exited 2024	Eli Lilly	–
Carisma Therapeutics2 periods Wellington Partners Life Sciences	Biotech	United States	Wellington Partners	2018	5yr	Exited 2023	Sesen Bio, Inc.	–
CinCor Pharma2 periods General Atlantic Growth Equity Fund	Biotech	United States	General Atlantic	2019	4yr	Exited 2023	AstraZeneca	–
Caraway Therapeutics Dementia Discovery Fund	Biotech	United States	SV Health Managers	2017	6yr	Exited 2023	Merck	–
Lexeo Therapeutics Lundbeckfonden BioCapital	Biotech	United States	Lundbeckfonden BioCapital	2021	2yr	Exited 2023	–	–
MAIA Biotechnology KIZOO Evergreen (Balance Sheet)	Biotech	United States	KIZOO Technology Capital	2019	3yr	Exited 2022	–	–
PepGen Oxford Science Enterprises Balance Sheet	Biotech	United States	Oxford Science Enterprises	2018	4yr	Exited 2022	–	–
Renovacor Innogest Capital II	Biotech	United States	Origine SGR	2019	3yr	Exited 2022	Rocket Pharmaceuticals	–
Senti Biosciences Leaps by Bayer	Biotech	United States	Leaps by Bayer	2021	1yr	Exited 2022	–	–
Amplyx Pharmaceuticals Lundbeckfonden BioCapital	Biotech	United States	Lundbeckfonden BioCapital	2017	4yr	Exited 2021	Pfizer	–
Century Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2019	2yr	Exited 2021	–	–
Eliem Therapeutics LifeArc Ventures	Biotech	United States	LifeArc	2021	0yr	Exited 2021	–	–
Recursion Pharmaceuticals Leaps by Bayer	Biotech	United States	Leaps by Bayer	2020	1yr	Exited 2021	–	–
AskBio Columbus Innvierte Life Science Fund I	Biotech	United States	Columbus Venture Partners	2016	4yr	Exited 2020	Bayer	–
Corvidia Therapeutics2 periods BioDiscovery 5	Biotech	United States	Andera Partners	2016	4yr	Exited 2020	Novo Nordisk	–
ArmaGen Technologies Boehringer Ingelheim Venture Fund	Biotech	United States	Boehringer Ingelheim Venture Fund	2014	6yr	Exited 2020	JCR Pharmaceuticals	–
Proteon Therapeutics TVM Life Science Ventures	Biotech	United States	TVM Capital Life Science	2006	14yr	Exited 2020	ArTara Therapeutics	–
Alector Dementia Discovery Fund	Biotech	United States	SV Health Managers	2016	3yr	Exited 2019	–	–
BlueRock Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2016	3yr	Exited 2019	Bayer	–
Tilos Therapeutics Boehringer Ingelheim Venture Fund	Biotech	United States	Boehringer Ingelheim Venture Fund	2016	3yr	Exited 2019	Merck	–
AgeX Therapeutics KIZOO Evergreen (Balance Sheet)	Biotech	United States	KIZOO Technology Capital	2017	1yr	Exited 2018	–	–
Algal Scientific Evonik Venture Capital	Biotech	United States	Evonik Venture Capital	2014	3yr	Exited 2017	Kemin Industries	–
CHASE Pharmaceuticals BioDiscovery 4	Biotech	United States	Andera Partners	2014	2yr	Exited 2016	Allergan	–
Pieris Sobera Capital Fund II	Biotech	United States	Sobera Capital	2013	1yr	Exited 2014	–	–
Ultragenyx HealthCap VI	Biotech	United States	HealthCap	2011	3yr	Exited 2014	–	–
Ultragenyx Pharmaceuticals Inc. HealthCap VI	Biotech	United States	HealthCap	2011	3yr	Exited 2014	–	–
bluebird bio TVM Life Science Ventures	Biotech	United States	TVM Capital Life Science	2004	9yr	Exited 2013	–	–
Omthera Pharmaceuticals Sofinnova Capital VI	Biotech	United States	Sofinnova Partners	2010	3yr	Exited 2013	AstraZeneca	–
Ferrokin Biosciences Inc. HealthCap VI	Biotech	United States	HealthCap	2009	3yr	Exited 2012	Shire	–
Tengion Inc HealthCap IV	Biotech	United States	HealthCap	2003	7yr	Exited 2010	–	–
Renovis Inc. HealthCap IV	Biotech	United States	HealthCap	2003	1yr	Exited 2004	–	–
sequenom Haspa BGM Evergreen	Biotech	United States	Haspa Beteiligungsgesellschaft	1998	6yr	Exited 2004	–	–
Nouscom5 periods Angelini Ventures	Biotech	United States	Angelini Ventures	2017	9yr	Active	–	–
Therini Bio3 periods Apollo Health Ventures Fund II	Biotech	United States	Apollo Health Ventures	2020	6yr	Active	–	–
Bloom Science2 periods Apollo Health Ventures Fund II	Biotech	United States	Apollo Health Ventures	2021	5yr	Active	–	–
Centessa Pharmaceuticals2 periods General Atlantic	Biotech	United States	General Atlantic	2021	5yr	Active	–	–
DMC Biotechnologies2 periods Michelin Ventures	Biotech	United States	Michelin Ventures	2019	7yr	Active	–	–
eGenesis2 periods Wellington Partners Life Sciences	Biotech	United States	Wellington Partners	2019	7yr	Active	–	–
Inspirna2 periods Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2021	5yr	Active	–	–
MaxCyte2 periods Vitruvian Investment Partnership IV	Biotech	United States	Vitruvian Partners	2019	7yr	Active	–	–
Mediar Therapeutics2 periods Sofinnova Capital X	Biotech	United States	Sofinnova Partners	2021	5yr	Active	–	–
Mozart Therapeutics2 periods Leaps by Bayer	Biotech	United States	Leaps by Bayer	2021	5yr	Active	–	–

Portfolio companies.21,000+ PE-backed.

Portfolio companies.
21,000+ PE-backed.